Clostridium difficile-associated colitis. Part 2: Therapy and prevention

被引:0
|
作者
Markus, P. M. [1 ]
机构
[1] Elisabeth Krankenhaus Essen Contilia GmbH, Akad Lehrkrankenhaus, Klin Allgemein Viszeral & Unfallchirurg, Klara Kopp Weg 1, D-45138 Essen, Germany
关键词
Pseudomembranous colitis; Clostridium difficile toxin A; Clostridium difficile toxin B Metronidazole; Vancomycin;
D O I
10.1007/s00053-012-0316-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Clostridium difficile is an anaerobic, Gram positive, spore-forming and toxin-producing bacillus. Colonization of the intestinal tract is facilitated by the administration of various antibiotics, in particular clindamycin, broad spectrum penicillins, fluorochinlones and cephalosporins. The clinical manifestations of C. difficile infections range from an asymptomatic carrier to fulminant disease with toxic megacolon. The cardinal clinical symptom is watery diarrhea accompanied by a pronounced leucocytosis. The most important initial step in the treatment of C. difficile - associated colitis is cessation of the responsible antibiotic. Treatment of non-severe C. difficile infection consists of oral metronidazole and patients with severe C. difficile - associated colitis are treated with oral vancomycin. The recurrence rate is high and a distinction must be made between a true reinfection with a different strain and a relapse of persistent diarrhea.
引用
收藏
页码:447 / 453
页数:7
相关论文
共 50 条